This article has been cited by
1The efficacy and safety comparison of docetaxel, cabazitaxel, estramustine, and mitoxantrone for castration-resistant prostate cancer: A network meta-analysis
Pan Song,Chuiguo Huang,Yan Wang
International Journal of Surgery.2018;56()133
[DOI]
2Immunotherapeutic role of cabazitaxel treatment in the activation of TLR3 signalling in metastatic castration-resistant prostate cancer in vitro
Asuman Deveci Ozkan,Gamze Guney Eskiler,Suleyman Kaleli,Elvan Sahin
Molecular Biology Reports.2022;49(2)1261
[DOI]
3Noninvasive urine metabolomics of prostate cancer and its therapeutic approaches: a current scenario and future perspective
Deepak Kumar,Kavindra Nath,Hira Lal,Ashish Gupta
Expert Review of Proteomics.2021;18(11)995
[DOI]
4Polysubstituted pyrrolidines linked to 1,2,3-triazoles: Synthesis, crystal structure, DFT studies, acid dissociation constant, drug-likeness, and anti-proliferative activity
Tuncay Ince,Riza Serttas,Bunyamin Demir,Hasan Atabey,Nurgul Seferoglu,Suat Erdogan,Ertan Sahin,Selma Erat,Yahya Nural
Journal of Molecular Structure.2020;1217(11)128400
[DOI]
5Cellular growth factors as prospective therapeutic targets for combination therapy in androgen independent prostate cancer (AIPC)
Bhavana Jonnalagadda,Sumathy Arockiasamy,Sriram Krishnamoorthy
Life Sciences.2020;259(11)118208
[DOI]
6The Nexus of Endocrine Signaling and Cancer: How Steroid Hormones Influence Genomic Stability
Shinjini Ganguly,Divya Naik,Andrew Muskara,Omar Y Mian
Endocrinology.2021;162(1)118208
[DOI]
7Low TLR and PSMA-TV predict biochemical response to abiraterone acetate in metastatic prostate cancer patients developing castration resistance after chemohormonal therapy at hormone-sensitive stage
Zhi-Bin Ke,Jia-Yin Chen,Qi You,Jiang-Bo Sun,Yu-Ting Xue,Xiao-Jian Ye,Shao-Hao Chen,Xue-Yi Xue,Xiong-Lin Sun,Dong-Ning Chen,Yong Wei,Qing-Shui Zheng,Shao-Ming Chen,Ning Xu
Journal of Cancer Research and Clinical Oncology.2022;162(1)118208
[DOI]
8Current Developments in Cellular Therapy for Castration Resistant Prostate Cancer: A Systematic Review of Clinical Studies
Christina Steinbach,Almas Merchant,Alexandru-Teodor Zaharie,Peter Horak,Maximilian Marhold,Michael Krainer
Cancers.2022;14(22)5719
[DOI]
9PI3K pathway in prostate cancer: All resistant roads lead to PI3K
Soonbum Park,Young Sik Kim,Davis Yeon Kim,Insuk So,Ju-Hong Jeon
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2018;1870(2)198
[DOI]
10Facile construction of dual-drug loaded nanoparticles for improvement synergistic chemotherapy in prostate cancer
Zhiqiang Ma,Tuo Ji,Guanghou Ji,Qingqing Niu,Weiwei Han
International Journal of Polymeric Materials and Polymeric Biomaterials.2022;1870(2)1
[DOI]
11Pneumocystis jirovecii pneumonia in a patient receiving chemotherapy for advanced prostatic cancer: a case report
Chen Tiantian,Yan Jin,Zhang Jing,Feng Jing,Jin Xiaoyan
Journal of International Medical Research.2022;50(6)030006052211053
[DOI]
12The Role of Rho GTPases in VEGF Signaling in Cancer Cells
Nada El Baba,Mohammad Farran,Elie Abi Khalil,Leila Jaafar,Isabelle Fakhoury,Mirvat El-Sibai
Analytical Cellular Pathology.2020;2020(6)1
[DOI]
13Sildenafil Potentiates the Therapeutic Efficacy of Docetaxel in Advanced Prostate Cancer by Stimulating NO-cGMP Signaling
Sakthivel Muniyan,Satyanarayana Rachagani,Seema Parte,Sushanta Halder,Parthasarathy Seshacharyulu,Prakash Kshirsagar,Jawed A. Siddiqui,Raghupathy Vengoji,Sanchita Rauth,Ridwan Islam,Kavita Mallya,Kaustubh Datta,Lei Xi,Anindita Das,Benjamin A. Teply,Rakesh C. Kukreja,Surinder K. Batra
Clinical Cancer Research.2020;26(21)5720
[DOI]
14Long Non-Coding RNA AC008972.1 as a Novel Therapeutic Target for Prostate Cancer
Qingqi Zeng,Jia Liu,Qijin Wu,Ruiyu Song,Wen Miao,Yuting Ma,Hongbao Yang
Cancer Biotherapy and Radiopharmaceuticals.2022;26(21)5720
[DOI]
15Chemotherapeutic Activities of Dietary Phytoestrogens against Prostate Cancer: From Observational to Clinical Studies
Md. Sohel,Habiba Sultana,Tayeba Sultana,Abdullah Al Mamun,Mohammad Nurul Amin,Md. Arju Hossain,Md. Chayan Ali,Suraiya Aktar,Armin Sultana,Zahed Bin Rahim,Sarmistha Mitra,Raju Dash
Current Pharmaceutical Design.2022;28(19)1561
[DOI]
16Treating De Novo Metastatic Castration-Sensitive Prostate Cancer With Visceral Metastases: An Evolving Issue
Giandomenico Roviello,Roberto Petrioli,Donata Villari,Alberto D’Angelo
Clinical Genitourinary Cancer.2021;19(1)83
[DOI]
17Biomolecule-functionalized nanoformulations for prostate cancer theranostics
Alberto Pranav,Partha Laskar,Meena Jaggi,Subhash C. Chauhan,Murali M. Yallapu
Journal of Advanced Research.2022;19(1)83
[DOI]
18Neoadjuvant Chemohormonal Therapy in Prostate Cancer Before Radical Prostatectomy: A Systematic Review and Meta-Analysis
Qingyu Ge,Hewei Xu,Dezhou Yue,Zongyao Fan,Zhengsen Chen,Jie Xu,Yiduo Zhou,Sicong Zhang,Jun Xue,Baixin Shen,Zhongqing Wei
Frontiers in Oncology.2022;12(1)83
[DOI]
19Anticancer Properties of Eisenia Foetida Proteins in Prostate Cancer Cells In Vitro
Asuman Deveci Ozkan,Gamze Guney Eskiler,Mehmet Sarihan,Nur Kazan,Ozlem Aksoy,Burcu Yuksel,Zeynep Betts
International Journal of Peptide Research and Therapeutics.2022;28(4)83
[DOI]
20Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAs
Milena Rizzo
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2021;1875(1)188481
[DOI]
21Time to second biochemical recurrence as a prognostic indicator in postprostatectomy patients who undergo salvage radiation therapy: An RTOG 9601 based post hoc analysis
Emily Chan Brodowsky,Akshay Sood,Mohit Butaney,Sami E. Majdalany,Alex Stephens,Nicholas Corsi,Austin J. Piontkowski,Ivan Rakic,Marcus Jamil,Deepansh Dalela,James O. Peabody,Craig G. Rogers,Firas Abdollah
The Prostate.2022;1875(1)188481
[DOI]
22Silica-based Nanoparticles as Drug Delivery Vehicles for Prostate Cancer Treatment
Steffi Tiburcius,Kannan Krishnan,Jae-Hun Yang,Fatemeh Hashemi,Gurwinder Singh,Deepika Radhakrishnan,Hoang Trung Trinh,Nicole M. Verrills,Ajay Karakoti,Ajayan Vinu
The Chemical Record.2020;1875(1)188481
[DOI]
23Solamargine Inhibits Prostate Cancer Cell Growth and Enhances the Therapeutic Efficacy of Docetaxel via Akt Signaling
Jianchao Ge,Pengyu Wang,Hangbin Ma,Jun Zhang,Sakthivel Muniyan
Journal of Oncology.2022;2022(1)1
[DOI]
24Synthesis and Evaluation of 18F-Enzalutamide, a New Radioligand for PET Imaging of Androgen Receptors: A Comparison with 16ß-18F-Fluoro-5a-Dihydrotestosterone
Inês F. Antunes,Rutger J. Dost,Hilde D. Hoving,Aren van Waarde,Rudi A.J.O Dierckx,Douwe F. Samplonius,Wijnand Helfrich,Philip H. Elsinga,Erik F.J. de Vries,Igle J. de Jong
Journal of Nuclear Medicine.2021;62(8)1140
[DOI]
25Dynamic changes in gene alterations during chemotherapy in metastatic castrate resistant prostate cancer
Winston Tan,Tiantian Zheng,Amy Wang,Joanna Roacho,Seng Thao,Pan Du,Shidong Jia,Jianjun Yu,Bonnie L. King,Manish Kohli
Scientific Reports.2022;12(1)1140
[DOI]
26Curcumin against Prostate Cancer: Current Evidence
Deborah Termini,Danja J. Den Hartogh,Alina Jaglanian,Evangelia Tsiani
Biomolecules.2020;10(11)1536
[DOI]
27Curcumin against Prostate Cancer: Current Evidence
Binil Eldhose,Gartrell C. Bowling
Biomolecules.2021;10(11)1
[DOI]
28Effects of Docetaxel plus Degarelix on Quality of Life and Vascular Endothelial Growth Factor in Patients with Prostate Cancer
Weiping Li,Dongbo Xu,Fudong Li,Pengcheng Chang,Bin Zhang,Xueliang Wu
Journal of Oncology.2022;2022(11)1
[DOI]
29Differential effect of body mass index (BMI) on outcomes of patients treated with docetaxel in prostate cancer - An exploratory analysis.
Saurav Verma,Shalabh Arora,Ranjit Kumar Sahoo,Prabhjot Singh,Brusabhanu Nayak,KP Haresh,Chandan J Das,Shamim A Shamim,Seema Kaushal,Atul Batra
Cancer Treatment and Research Communications.2022;31(11)100520
[DOI]
30Differential effect of body mass index (BMI) on outcomes of patients treated with docetaxel in prostate cancer - An exploratory analysis.
Iago Dillion Lima Cavalcanti
Cancer Treatment and Research Communications.2022;31(11)201
[DOI]
31Polygodial, a Sesquiterpene Dialdehyde, Activates Apoptotic Signaling in Castration-Resistant Prostate Cancer Cell Lines by Inducing Oxidative Stress
Reshmii Venkatesan,Mohamed Ali Hussein,Leah Moses,Jennifer S. Liu,Salman R. Khetani,Alexander Kornienko,Gnanasekar Munirathinam
Cancers.2022;14(21)5260
[DOI]
32Evaluation of JQ1 Combined With Docetaxel for the Treatment of Prostate Cancer Cells in 2D- and 3D-Culture Systems
Yipeng Xu,Gabriela Pachnikova,Dorothea Przybilla,Reinhold Schäfer,Yingying Cui,Dan Zhou,Zihao Chen,An Zhao,Ulrich Keilholz
Frontiers in Pharmacology.2022;13(21)5260
[DOI]
33SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis
Xun Shangguan,Jianli He,Zehua Ma,Weiwei zhang,Yiyi Ji,Kai Shen,Zhiying Yue,Wenyu Li,Zhixiang Xin,Quan Zheng,Ying Cao,Jiahua Pan,Baijun Dong,Jinke Cheng,Qi Wang,Wei Xue
Nature Communications.2021;12(1)5260
[DOI]
34Management of Long Bones Metastatic Disease: Concepts That We All Know but Not Always Remember
Marcos R Gonzalez,Mayte Bryce-Alberti,Juan Pretell-Mazzini
Orthopedic Research and Reviews.2022;Volume 14(1)393
[DOI]
35Prognostic role of 11C-choline PET/CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapy
Masaya Jimbo,Jack R. Andrews,Mohamed E. Ahmed,Ayca Dundar,R. Jeffrey Karnes,Alan H. Bryce,Ayse T. Kendi,Eugene D. Kwon,Val J. Lowe,Michael S. Bold
The Prostate.2022;82(1)41
[DOI]
36Nanosystem functionalization strategies for prostate cancer treatment: a review
Jennifer Thayanne Cavalcante de Araújo,Jonatas Lobato Duarte,Leonardo Delello Di Filippo,Victor Hugo Sousa Araújo,Gabriela Corrêa Carvalho,Marlus Chorilli
Journal of Drug Targeting.2021;29(8)808
[DOI]
37StarD13: a potential star target for tumor therapeutics
Leila Jaafar,Zeinab Chamseddine,Mirvat El-Sibai
Human Cell.2020;33(3)437
[DOI]
38Nanovectorization of Prostate Cancer Treatment Strategies: A New Approach to Improved Outcomes
Kenneth Omabe,Clément Paris,François Lannes,David Taïeb,Palma Rocchi
Pharmaceutics.2021;13(5)591
[DOI]
39Zingerone suppresses cell proliferation via inducing cellular apoptosis and inhibition of the PI3K/AKT/mTOR signaling pathway in human prostate cancer PC-3 cells
Shengqiang Qian,Huiying Fang,Lu Zheng,Mei Liu
Journal of Biochemical and Molecular Toxicology.2021;35(1)591
[DOI]
40Aptamer-conjugated mesoporous polydopamine for docetaxel targeted delivery and synergistic photothermal therapy of prostate cancer
Liang Dai,Dapeng Wei,Jidong Zhang,Tianyu Shen,Yuming Zhao,Junqiang Liang,Wangteng Ma,Limin Zhang,Qingli Liu,Yue Zheng
Cell Proliferation.2021;54(11)591
[DOI]
41Implications and effects of COVID-19 on diagnosis and management of prostate cancer
Vinson Wai-Shun Chan,Aqua Asif,Jasmine Sze-Ern Koe,Alexander Ng,Chi Fai Ng,Jeremy Yuen-Chun Teoh
Current Opinion in Urology.2022;32(3)311
[DOI]
42Sensitizing the cytotoxic action of Docetaxel induced by Pentoxifylline in a PC3 prostate cancer cell line
Martha E. Cancino-Marentes,Georgina Hernández-Flores,Pablo Cesar Ortiz-Lazareno,María Martha Villaseñor-García,Eduardo Orozco-Alonso,Erick Sierra-Díaz,Raúl Antonio Solís-Martínez,Claudia Carolina Cruz-Gálvez,Alejandro Bravo-Cuellar
BMC Urology.2021;21(1)311
[DOI]
43The problem of choosing the tactics of managing patients with high and very high risk of prostate cancer: a review of the literature
N. N. Buevich,S. A. Protsenko,A. K. Nosov,S. A. Reva,A. S. Artemyeva,M. V. Berkut
Cancer Urology.2019;15(1)117
[DOI]
44Exosomal circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) enhances the docetaxel resistance of prostate cancer via the microRNA-136-5p/tribbles homolog 1 pathway
Xiaoliang Tan,Xiaosen Song,Bo Fan,Ming Li,Aili Zhang,Long Pei
Anti-Cancer Drugs.2022;33(9)871
[DOI]
45Pharmacological Small Molecules against Prostate Cancer by Enhancing Function of Death Receptor 5
Xia Gan,Yonghong Liu,Xueni Wang
Pharmaceuticals.2022;15(8)1029
[DOI]
46Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles
Yougan Chen,Yuanyuan Deng,Chenyao Zhu,Congming Xiang
Biomedicine & Pharmacotherapy.2020;127(8)110181
[DOI]
47Synthesis, structure and in vitro antiproliferative effects of alkyne-linked 1,2,4-thiadiazole hybrids including erlotinib- and ferrocene-containing derivatives
Mohammed Boulhaoua,Tibor Pasinszki,Ana Torvisco,Rita Oláh-Szabó,Szilvia Bosze,Antal Csámpai
RSC Advances.2021;11(46)28685
[DOI]
48Analysis of Clinical Trials on Therapies for Prostate Cancer in Mainland China and Globally from 2010 to 2020
Kun Chen,Kehua Jiang,Lannan Tang,Xiaolong Chen,Jianxin Hu,Fa Sun
Frontiers in Oncology.2021;11(46)28685
[DOI]
49Analysis of Clinical Trials on Therapies for Prostate Cancer in Mainland China and Globally from 2010 to 2020
Binil Eldhose,Gartrell C. Bowling
Frontiers in Oncology.2022;11(46)985
[DOI]
50IND-2, a Quinoline Derivative, Inhibits the Proliferation of Prostate Cancer Cells by Inducing Oxidative Stress, Apoptosis and Inhibiting Topoisomerase II
Swapnaa Balaji,Rabin Neupane,Saloni Malla,Rahul Khupse,Haneen Amawi,Shikha Kumari,Diwakar Bastihalli Tukaramrao,Srestha Chattopadhyay,Charles R. Ashby,Sai H. S. Boddu,Chandrabose Karthikeyan,Piyush Trivedi,Dayanidhi Raman,Amit K. Tiwari
Life.2022;12(11)1879
[DOI]
51Current status of intratumour microbiome in cancer and engineered exogenous microbiota as a promising therapeutic strategy
Jiawen Chen,Ting Li,Jianhao Liang,Qiqi Huang,Jian-Dong Huang,Yiquan Ke,Haitao Sun
Biomedicine & Pharmacotherapy.2022;145(11)112443
[DOI]
52Co-delivery of the autophagy inhibitor si-Beclin1 and the doxorubicin nano-delivery system for advanced prostate cancer treatment
Chuling Hu,Fenfen Gu,Chunai Gong,Qingming Xia,Yuan Gao,Shen Gao
Journal of Biomaterials Applications.2022;36(7)1317
[DOI]
53AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption
Navid Sobhani,Praveen Kumar Neeli,Alberto D’Angelo,Matteo Pittacolo,Marianna Sirico,Ilaria Camilla Galli,Giandomenico Roviello,Gabriella Nesi
International Journal of Molecular Sciences.2021;22(11)5515
[DOI]
54Finding an easy way to harmonize: a review of advances in clinical research and combination strategies of EZH2 inhibitors
Chen Li,Yan Wang,Yueqing Gong,Tengrui Zhang,Jiaqi Huang,Zhen Tan,Lixiang Xue
Clinical Epigenetics.2021;13(1)5515
[DOI]
55Holistic Approach to the Diagnosis and Treatment of Patients with Tumor Metastases to the Spine
Hanna Nowak,Dominika Maria Szwacka,Monika Pater,Wojciech Krzysztof Mrugalski,Michal Grzegorz Milczarek,Magdalena Staniszewska,Roman Jankowski,Anna-Maria Barciszewska
Cancers.2022;14(14)3480
[DOI]
56Clinical studies of chemotherapy efficacy in combination with androgenic deprivation in patients with oligometastatic hormone-sensitive prostate cancer
S. V. Popov
Medical Council.2019;14(19)170
[DOI]
57Self-Assembled Nanomicellar Formulation of Docetaxel as a Potential Breast Cancer Chemotherapeutic System
Meshal Alshamrani,Navid J. Ayon,Abdullah Alsalhi,Omowumi Akinjole
Life.2022;12(4)485
[DOI]
58Immune Checkpoints, Inhibitors and Radionuclides in Prostate Cancer: Promising Combinatorial Therapy Approach
Mankgopo M. Kgatle,Tebatso M. G. Boshomane,Ismaheel O. Lawal,Kgomotso M. G. Mokoala,Neo P. Mokgoro,Nico Lourens,Kalevo Kairemo,Jan Rijn Zeevaart,Mariza Vorster,Mike M. Sathekge
International Journal of Molecular Sciences.2021;22(8)4109
[DOI]
59CORR Insights®: Does a Competing Risk Analysis Show Differences in the Cumulative Incidence of Revision Surgery Between Patients with Oncologic and Nononcologic Conditions After Distal Femur Replacement?
Carlos A. Higuera-Rueda
Clinical Orthopaedics & Related Research.2020;478(5)1074
[DOI]
60Decreased biochemical progression in patients with castration-resistant prostate cancer using a novel mefenamic acid anti-inflammatory therapy: A randomized controlled trial
Jos? Guzman-Esquivel,Martha Mendoza-Hernandez,Daniel Tiburcio-Jimenez,Oscar Avila-Zamora,Josuel Delgado-Enciso,Luis De-Leon-Zaragoza,Juan Casarez-Price,Iram Rodriguez-Sanchez,Margarita Martinez-Fierro,Carmen Meza-Robles,Alejandro Barocio-Acosta,Luz Baltazar-Rodriguez,Sergio Zaizar-Fregoso,Jorge Plata-Florenzano,Iv?n Delgado-Enciso
Oncology Letters.2020;478(5)1074
[DOI]
Feedback

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal